HQL
Tekla Life Sciences Investors
17.40$
+0.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | +10.2% | -85.4% | +6,126.3% | -82.2% | -100.0% | -654.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -288.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +10.2% | -85.4% | +6,126.3% | -100.0% | – | -106.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,460.0% | -74.4% | +410.0% | -5.9% | -3.1% | -8.6% | +15.3% | -693.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -74.6% | +406.3% | -11.1% | -18.1% | -3.4% | +28.1% | +52.1% | -4.5% | +11.3% | -35.6% | -52.6% | +211.1% | -8.7% | -99.9% | +48.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +2,718.4% | -89.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -74.6% | +406.3% | -11.1% | -18.1% | -3.4% | +28.1% | – | -117.6% | +11.3% | -35.6% | -3.9% | +1,520.5% | -82.2% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -166.7% | – | -140.0% | – | – | – | – | – | -200.0% | – | – | -69.3% | -195.4% | – | – | – | – | – | – | – | -155.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +10.2% | -85.4% | +6,126.3% | -82.2% | -100.0% | -654.9% | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.